Product Information
CLORAZEPATE 3.75 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.5815 per EA under NDC 51672404202. Its NADAC has been published 630 times since Nov 28, 2013.
FDA first approved this application on Apr 27, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3.75 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672404202
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLORAZEPATE DIPOTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA075731FDA Approved
4/27/2000
TE Code
AB
On Market Since
4/27/2000
Pharmacological Classes
Price Statistics
The NADAC for CLORAZEPATE 3.75 MG TABLET has been published 630 times since Nov 28, 2013, and over the history we have for it it has risen 293.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5815 per EA |
|---|---|
| All-time high | $2.7560 (May 15, 2019) |
| All-time low | $0.1383 (Dec 18, 2013) |
| 52-week high | $0.8878 |
| 52-week low | $0.5815 |
| Median price | $0.9208 |
| Average price | $0.9114 |
| Largest weekly change | +783.5% (Mar 22, 2017) |
| Weeks tracked | 630 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLORAZEPATE 3.75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLORAZEPATE 3.75 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.5815 per EA (NDC 51672404202), effective Aug 19, 2026.
How has the price of CLORAZEPATE 3.75 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLORAZEPATE 3.75 MG TABLET has risen 293.3%. It has been tracked across 630 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLORAZEPATE 3.75 MG TABLET?
Since Nov 28, 2013, the NADAC for CLORAZEPATE 3.75 MG TABLET has ranged from a low of $0.1383 (Dec 18, 2013) to a high of $2.7560 (May 15, 2019), with a median of $0.9208 per EA.
Are there cheaper alternatives to CLORAZEPATE 3.75 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLORAZEPATE 3.75 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLORAZEPATE 3.75 MG TABLET?
CLORAZEPATE 3.75 MG TABLET (NDC 51672404202) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.